Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Pfeiler, Georg, DeMichele, Angela, Dueck, Amylou C, Fesl, Christian, Gnant, Michael, Mayer, Erica L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803349/
https://www.ncbi.nlm.nih.gov/pubmed/35114114
http://dx.doi.org/10.1016/S1470-2045(21)00708-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803349/
https://www.ncbi.nlm.nih.gov/pubmed/35114114
http://dx.doi.org/10.1016/S1470-2045(21)00708-7

Ejemplares similares